Ketan Mathavan

Affiliations

Fate Therapeutics, San Diego, CA, United States.

Publications (2)

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma.

Frontiers in immunology

Avec: Michael W Moles , Henry Erdlei , Lutz Menzel , Marialucia Massaro , Agnese Fiori , Mario Bunse , Moritz Schrimpf , Kerstin Gerlach , Venugopal Gudipati , John Reiser , Ketan Mathavan , Jodie P Goodrich , Johannes B Huppa , Jan Krönke , Bahram Valamehr , Uta E Höpken , Armin Rehm

Endoplasmic reticulum transmembrane protein TMTC3 contributes to O-mannosylation of E-cadherin, cellular adherence, and embryonic gastrulation.

Molecular biology of the cell

Avec: Jill B Graham , Johan C Sunryd , Ketan Mathavan , Emma Weir , Ida Signe Bohse Larsen , Adnan Halim , Henrik Clausen , Hélène Cousin , Dominque Alfandari , Daniel N Hebert

Réseau de co-auteurs

Michael W Moles 1 collaboration

Henry Erdlei 1 collaboration

Lutz Menzel 1 collaboration

Marialucia Massaro 1 collaboration

Agnese Fiori 1 collaboration

Mario Bunse 1 collaboration

Moritz Schrimpf 1 collaboration

Kerstin Gerlach 1 collaboration

Venugopal Gudipati 1 collaboration

John Reiser 1 collaboration

Jodie P Goodrich 1 collaboration

Johannes B Huppa 1 collaboration

Jan Krönke 1 collaboration

Bahram Valamehr 1 collaboration

Uta E Höpken 1 collaboration

Armin Rehm 1 collaboration

Jill B Graham 1 collaboration

Johan C Sunryd 1 collaboration

Emma Weir 1 collaboration

Ida Signe Bohse Larsen 1 collaboration

Adnan Halim 1 collaboration

Henrik Clausen 1 collaboration

Hélène Cousin 1 collaboration

Dominque Alfandari 1 collaboration

Daniel N Hebert 1 collaboration